DePuy ASR Hip Implant Recall Lawyer

NewsInferno.com reports that seven New York residents have filed lawsuits against the makers of the DePuy ARS hip implant claiming that they were forced to undergo hip revision surgery after their AST hip implant prematurely failed.

The lawsuit claims that DePuy Orthopaedics, a division of Johnson & Johnson, knew years before the August 2010 DePuy hip recall that the implant triggered complications.

One of the New York plaintiffs, Ronald Nigro, reported that his DePuy ASR hip implant failed in February 2009 forcing him to undergo revision surgery in October after experiencing severe inflammation that made it difficult for him …

The majority of patients, who are concerned about recent DePuy recalls, are also anxious about who has to repay all kinds of expenses associated with their artificial hip and knee implants’ untimely failures. The New York Times reports that it is practically never the implants’ producer.

As a rule, hip or knee replacement implants should serve for about 15 years. However, in some cases, they appear to be defective earlier due to their design faults or other suchlike problems. This is the main reason for the recently issued DePuy hip recall. Before issuing the recall, Johnson &Johnson DePuy Orthopaedics, the maker of DePuy hip and knee replacement devices, announced that one of its devices, the ASR hip replacement implant, seems to have considerable rates of failures. Nonetheless, failure reviews have already been observed several years prior to the company’s warning. Patients, who received defective hip and knee replacement implants had to undergo painful and expensive revision surgeries, which implied a long recovery period. FDA has got over 300 untimely revision surgeries complaints associated with the implants, which later became the objects of the DePuy hip joint recall. …

It is reported that some orthopedic surgeons are not satisfied with metal-on-metal hip replacement implants’ quality. The majority of them admit that they consider it necessary to reduce their application in hip replacement surgeries. In this respect, recent DePuy hip recall did not become a surprise for them.

DePuy hip replacement metal-on-metal devices are used throughout the US in the considerable number of hip replacement and hip resurfacing surgeries. Initially, hip replacement chromium and cobalt implants, were expected to be more secure and long-lasting as compared to models applied earlier.

Recent investigations defined that metal-on-metal hip replacement devices could have certain faults. Typically, they are expected to serve for over 15 years. However, the New York Times survey discovered that in a number of cases a revision surgery is required during the first years of their exploitation.

In accordance with the survey, DePuy hip replacement implants may wear out rather quickly, producing high levels of metallic fragments that are absorbed by the patients’ blood, thus leading to DePuy hip metal poisoning. Moreover, it is assumed that high concentrations of metal fragments may result in the formation of benign tissue tumors and even in bone damage. This problem concerns up to 3 percent of patients who received DePuy hip implants. …

This year a powerful pharmaceutical company, Johnson & Johnson, is forced to issue its tenth recall, which is associated with J&J DePuy Orthopaedics artificial joint manufacturing.

The Associated Press reports that J&J DePuy Orthopaedics, Inc. is issuing their DePuy recall, which involves its two hip replacement implants, notably ASR XL Acetabular System and ASR Hip Resurfacing System. It is emphasized that DePuy hip recall is influenced by the considerable rate of revision surgeries, which proved to be higher than it was initially supposed.

In fact, there is nothing surprising in DePuy recall, because of the growing number of orthopedic surgeons, who are not satisfied with the quality of metal-on-metal hip replacement implants. Many of them even intended to reduce their usage in hip replacement surgeries.

DePuy hip replacement implants are widely used in the US in the prevailing number of hip replacement and hip resurfacing surgeries. Originally, hip replacement implants, produced of chromium and cobalt, were expected to be more secure and long-lasting as compared to models, which were used earlier. However, recent reviews showed that metal-on-metal DePuy implants had substantial failures, which resulted in the above mentioned DePuy recalls. …

DePuy ASR recall was issued by DePuy Orthopadedics worldwide. It becomes clear now that multiple litigations against this company are instituted worldwide as well. In accordance with Australian review, one man has already decided to enroll into the class action litigation, which is to be filed on behalf of patients who faced health complications caused by defective DePuy hip replacement implants. Taking into consideration that the number of Australians, who received a recalled implant, is rather considerable, more claimants are expected to join the DePuy ASR litigation.

National Joint Registry of England and Wales announced that nearly 13 percent of people, who had DePuyASR hip devices implanted, did not have any other alternative but to have the revision surgery conducted within five years after receiving them. This information became decisive in issuing DePuy recalls, which concerned mainly the ASR XL Acetabular System (a hip socket, applied in conventional hip replacement surgeries) and the ASR Hip Resurfacing System (used in partial hip replacement procedures). The ASR XL Acetabular System was the one to be officially approved in the US.

Prior to issuing the DePuy hip recall in Australia, DePuy Orthopaedics had officially documented complaints related to the recalled implants. In March, the company notified people that one of its hip replacement implants had shown a high rate of failures. FDA reported that over 300 people stated that they had faced certain problems associated with their DePuy hip implants since 2008. …

If you have a DePuy ASR hip implant and have suffered from such problems as hip pain, inflammation or difficulty walking, it may indicate that your implant has certain failures, which may threaten your health.  In August, DePuy Orthopaedics has issued a DePuy ASR recall, which was explained by the fact that a number of patients had specific complaints because of their defective hip implants.

Typically, any hip implant should serve for over 15 years. Nonetheless, recent medical investigations revealed that nearly 13 percent of people, who had DePuyASR hip devices implanted, were forced to have the revision surgery conducted within five years after receiving them. The fact was confirmed by the National Joint Registry of England and Wales. This information became a powerful incentive for DePuy Orthopaedics to issue its DePuy hip recall, which concerned both the ASR Hip Resurfacing System and the ASR XL Acetabular System.

It is reported that more than 93000 patients in different countries of the world have received one of the above mentioned recalled hip implants. Representatives of Johnson & Johnson DePuy Orthopaedics, Inc. emphasize that the main objective of the DePuy recall is to conduct additional medical testing and monitoring in order to make sure that patients’ hip implants function properly. If some problems are determined, patients may be recommended to undergo a revision surgery.

Nowadays, more and more US residents, who experience DePuy ASR hip implants’ failures, decide to institute DePuy lawsuits. …